 |
Alzheimer Research UK (ARUK) (2014-2019) |
| Alzheimer’s Research UK is the leading dedicated charity funder of dementia research in the world. We are committed to funding to best biomedical research to fulfil our vision of a world where people are free from the fear, harm and heartbreak of dementia.Our focus is to accelerate the ‘bench-to-bedside’ journey and we have launched a number of initiatives to make our ambitious Research Strategy a reality. Our £30 million Drug Discovery Alliance is one of the largest coordinated academic efforts in the world to boost the early-stage dementia drug discovery pipeline. We also partner extensively with industry including through the Dementia Consortium – a unique charity-private partnership to fund robust target validation. We are pleased to contribute to a number of UK and global partnerships, including the CCNA.
As a charity we are also working hard to raise dementia awareness across society and to shape and influence policy on dementia research by working with key decision makers in government and beyond. |
|
|
|
|
 |
Eli Lilly (2016-2017) |
| Eli Lilly and Company is a global healthcare leader that unites caring with discovery to make life better for people around the world. We were founded more than a century ago by Colonel Eli Lilly, who was committed to creating high quality medicines that meet people’s needs, and today we remain true to that mission in all our work. Lilly employees work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and contribute to our communities through philanthropy and volunteerism.
Eli Lilly Canada was established in 1938, the result of a research collaboration with scientists at the University of Toronto which eventually produced the world’s first commercially-available insulin. Lilly Canada now employs nearly 400 people across the country, working in the areas of oncology, diabetes, autoimmunity, neurodegeneration, and pain. To learn more about Lilly Canada, please visit us at www.lilly.ca. |
|
|
|
|
 |
Michael Smith Foundation for Health Research (MSFHR) (2014-2018) |
| The Michael Smith Foundation for Health Research empowers British Columbia’s (BC) best and brightest health researchers to pursue world-class innovation and stretch the bounds of what health research can achieve. The Foundation helps BC’s health research community discover solutions to our greatest health challenges; connect knowledge and action on provincial priorities; and engage partners to improve the research enterprise. | |
|
|
|
 |
Nova Scotia Health Research Foundation (NSHRF) (2014-2019) |
| The Nova Scotia Health Research Foundation (NSHRF) exists to improve the health of Nova Scotians through health research. This is accomplished by working with stakeholders, including the provincial government, health authorities, and health researchers on a number of initiatives and funding opportunities.
Through its support of researchers, students and knowledge translation activities, the Foundation is maximizing the impact of health research on informed decision making in Nova Scotia and across the country. |
|
|
|
|
 |
Pfizer (2014-2019) |
| Pfizer Canada Inc. is the Canadian operation of Pfizer Inc., one of the world’s leading biopharmaceutical companies. Our diversified health care portfolio includes some of the world’s best known and most prescribed medicines and vaccines. Every day, Pfizer Canada employees work to bring therapies to patients that significantly improve patients’ lives. Pfizer is a major contributor to health research in Canada. We apply science and our global resources to improve the health and well-being of Canadians at every stage of life. Our commitment is reflected in everything Pfizer does, from our disease awareness initiatives to our community partnerships. | |
|
|
|
 |
Robin and Barry Picov Family Foundation (2014-2019) |
| The Robin and Barry Picov Family Foundation is excited to participate as a partner of the CCNA through the auspices of the Women’s Brain Health Initiative. In addition to better understanding the impact of brain-aging diseases on both men and women, our hope is that the research proposed will result in better treatment and, ideally, innovative prevention strategies, for all neurodegenerative diseases in aging. | |
|
|
|
 |
Sanofi (2014-2017) |
| Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients’ needs. Sanofi has core strengths in diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and Genzyme. | |
|
|
|
 |
Women’s Brain Health Initiative (WBHI) (2014-2019) |
| It was frightening to learn that women suffer from depression, stroke and dementia twice as much as men as they age, and an astounding 70 percent of new Alzheimer’s patients are women. Yet research still focuses on men. We want to correct this research bias. Women’s Brain Health Initiative is a charitable non-profit organization with a mandate to provide education and fund research to combat brain-aging diseases that affect women. |
